#multiple myeloma

All articles tagged with "multiple myeloma"

Medical Xpress reports that a single infusion of ciltacabtagene autoleucel led to a 100% MRD-negativity rate in the studied group.
The reported patients had high-risk smoldering multiple myeloma.
The short source text does not include study size, durability, or safety details, leaving key questions open.

DT Editorial Team·Apr 20, 2026·via medicalxpress.com

CHMP recommended four new drugs and a subcutaneous form of Sanofi’s Sarclisa.
The decision is an important scientific milestone ahead of final European Commission action.
The Sarclisa update highlights how new formulations can become meaningful regulatory and commercial events.

DT Editorial Team·Mar 29, 2026·via endpoints.news

A phase 1 study tested an anti-BCMA CAR-T approach generated inside the body rather than manufactured outside it.
Five heavily pretreated patients received a single intravenous infusion without leukapheresis, ex vivo manufacturing, or lymphodepleting chemotherapy.
Four of five patients had objective responses, including three stringent complete remissions.
All patients had grade 3 or higher adverse events, highlighting the therapy’s risks despite the simplified workflow.

DT Editorial Team·Mar 27, 2026·via nature.com